Plug-in (computing)

OASIS Medical Inc. Brings a New Shape to Punctal Occlusion

Retrieved on: 
Saturday, April 6, 2024
Plug-in (computing), Oasis, ASCRS, OASIS, Catalog, Dry eye syndrome, Birth control

GLENDORA, Calif., April 6, 2024 /PRNewswire/ -- OASIS® Medical Inc., manufacturer and distributor of disposable surgical solutions and dry eye solution brands Oasis TEARS® and SOFT PLUG® punctal plugs launch the SOFT PLUG® Extended Duration 180-T Tapered Plug at ASCRS booth 2675 in Boston.

Key Points: 
  • SOFT PLUG® Extended Duration 180-T Tapered Plugs are designed with a .25mm tapered end for ease of insertion into the punctal opening.
  • The plug then gradually widens to a .6mm diameter at the top end to contribute to occlusion of the canaliculus.
  • SOFT PLUG® Extended Duration 180-T Tapered Plugs are intended to temporarily block tear drainage by the occlusion of the canaliculus to temporarily treat dry eye syndrome and the dry eye components of various ocular surface diseases.
  • The addition of SOFT PLUG® Extended Duration 180-T Tapered Plug to OASIS line of dry eye solutions brings a robust selection of punctal occlusion to eye care providers in the US.

SparkPlug and Distru Partner to Streamline Operations for Smokiez

Retrieved on: 
Tuesday, March 5, 2024
ERP, SAN, Sale, Plug-in (computing), Region, Partnership

The partnership aims to help Smokiez, a multi-state edibles producer and distributor, streamline operations, minimize errors, and boost retail sales through data-driven insights.

Key Points: 
  • The partnership aims to help Smokiez, a multi-state edibles producer and distributor, streamline operations, minimize errors, and boost retail sales through data-driven insights.
  • "We're thrilled to be partnering with the team at Distru," said Jacob Levin, COO of SparkPlug.
  • "As highlighted by Smokiez, Distru has provided centralized data and reporting that has streamlined complex spreadsheets.
  • The partnership between SparkPlug and Distru demonstrates the power of best-of-breed cannabis tech solutions working together to solve unique industry challenges.

SparkPlug Joins Toast Partner Ecosystem

Retrieved on: 
Tuesday, August 15, 2023
Business development, Partnership, Restaurant, Face, Culture, Business, Reward, Job satisfaction, Plug-in (computing), Digital technology, SAN, Entrepreneurship, ROI, Morale, Food delivery, Management, Gelato, Toast

SAN FRANCISCO, Aug. 15, 2023 /PRNewswire/ -- Today, SparkPlug and Toast announced their official partnership, enabling restaurants to motivate and reward frontline staff.

Key Points: 
  • SAN FRANCISCO, Aug. 15, 2023 /PRNewswire/ -- Today, SparkPlug and Toast announced their official partnership, enabling restaurants to motivate and reward frontline staff.
  • It works with integration partners in its Toast Partner Ecosystem , a curated portfolio of more than 200 partners who deliver specialized technology and services to help restaurant operators increase sales, engage guests, and keep employees happy.
  • "We are thrilled to welcome SparkPlug to the Toast Partner Ecosystem, and delighted to offer our customers automated and personalized staff incentives through SparkPlug's platform," says Keith Corbin, Senior Director, Business Development from Toast.
  • Restaurants benefit from the SparkPlug and Toast integration in multiple ways:
    Real-time ROI tracking: View incentive campaign ROI, period-over-period sales lift, and employee standings via a secure analytics dashboard.

Global Dry Eye Disease Market Size, Share, Growth Analysis, By Product, By Distribution Channel - Industry Forecast 2022-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 28, 2023
Pharmaceutical, Health, Optical, Telehealth, Therapy, Prevalence, Pharmacy, Smartphone, MEA, Medicine, Market, Telecanthus, Patient, Machine learning, Plant growth analysis, Artificial intelligence, Growth, Plug-in (computing), Growth hormone secretagogue receptor, Disease, Pharmaceutical industry

The "Global Dry Eye Disease Market Size, Share, Growth Analysis, By Product, By Distribution Channel - Industry Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Dry Eye Disease Market Size, Share, Growth Analysis, By Product, By Distribution Channel - Industry Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global dry eye disease market is segmented based on the product, distribution channel and region.
  • Another barrier to the market's potential expansion is the absence of potent treatments for severe dry eye disease.
  • The demand for less costly, riskier, and the all solutions for dry eye disease is yet another factor driving market expansion.

Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com

Retrieved on: 
Friday, December 23, 2022
Pharmaceutical, Health, Optical, Government, Element, MEA, Research, Pharmacy, USD, Risk, Growth, Patient, Growth hormone secretagogue, Plug-in (computing), Duane syndrome, Diabetes, Incidence, Prevalence, Pharmaceutical industry, LASIK

Global Dry Eye Disease Market size was valued at USD 5.95 billion in 2021, and it is expected to reach a value of USD 8.21 billion by 2028, at a CAGR of 4.71% during the forecast period (2022- 2028).

Key Points: 
  • Global Dry Eye Disease Market size was valued at USD 5.95 billion in 2021, and it is expected to reach a value of USD 8.21 billion by 2028, at a CAGR of 4.71% during the forecast period (2022- 2028).
  • Global geriatric population growth is predicted to result in an increase in the number of patients with dry eye disease.
  • The global dry eye disease market is segmented based on the product, distribution channel and region.
  • A significant growth driver for the dry eye disease market will be the rising public awareness of dry eye disease brought on by numerous government and non-government efforts.

$1,400,000 in Settlements Reached with Oxygen Sensors and Spark Plugs Manufacturers in Price Fixing Class Action Lawsuits

Retrieved on: 
Monday, June 27, 2022
Class representative, DENSO, Oxygen sensor, Notice, LLP, P.C, NGK, Settlement, Hearing, District court, Denso, United States district court, Plug-in (computing), Wharf (Holdings) Ltd. v. United International Holdings, Inc., Béliveau, Hitachi, Southern Division, Parent, Youth Service America, Oxygen

The lawsuits claimed that Defendants conspired to raise, fix, maintain, and stabilize prices, rig bids, and allocate the supply of Oxygen Sensors and Spark Plugs sold in the United States, in violation of federal antitrust laws.

Key Points: 
  • The lawsuits claimed that Defendants conspired to raise, fix, maintain, and stabilize prices, rig bids, and allocate the supply of Oxygen Sensors and Spark Plugs sold in the United States, in violation of federal antitrust laws.
  • The settlements affect those who purchased Oxygen Sensors and Spark Plugs in the United States between January 1, 2000 and February 4, 2019.
  • A Notice of Proposed Settlements (the "Notice") was mailed to potential Settlement Class members on or about June 20, 2022.
  • The Notice and other important documents related to the settlements can be accessed at www.AutoPartsAntitrustLitigation.com , or by calling 877-890-8128 or writing to Oxygen Sensors and Spark Plugs Direct Purchaser Antitrust Litigation, P.O.

FDA Approves First Generic of Restasis

Retrieved on: 
Wednesday, February 2, 2022
Eye, Sensation, Patient, Immune system, Food, Tears, Center, Plasma protein binding, Skin, Center for Drug Evaluation and Research, Itch, Keratoconjunctivitis, Stinger, Inflammation, Research, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Itchy, Epiphora, Lists of diseases, Punctal plug, Duane syndrome, Cover My Eyes (Pain and Heaven), FDA, Blood, Plug-in (computing), Science, Pharmaceutical industry, Medical device, Generic drug, Ciclosporin

"Today's approval reflects the FDA's continued commitment to advancing patient access to lower-cost, high-quality generic drug products that are as safe and effective as their brand name counterparts.

Key Points: 
  • "Today's approval reflects the FDA's continued commitment to advancing patient access to lower-cost, high-quality generic drug products that are as safe and effective as their brand name counterparts.
  • Supporting development and expanding opportunities to bring complex generic drugs to the market is a major focus of our efforts to help improve competition and help lower drug prices."
  • The FDA has taken a multifaceted approach to encourage development of complex generics through the Generic Drug User Fee Amendments (GDUFA) program.
  • The sponsor of the generic cyclosporine ophthalmic emulsion0.05% single-use vialsapproved today is Mylan Pharmaceuticals Inc.

Worldwide Novel Ocular Drug Delivery Devices Industry to 2030 - Featuring Aciont, AcuFocus and Allergan Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, November 15, 2021
Pharmaceutical, Health, Optical, Population, Drug, Adoption, Korea Disease Control and Prevention Agency, Industry, WHO, Type, USD, Plug-in (computing), Diabetic retinopathy, Eye, Punctal plug, World, World Health Organization, Cornea, CDC, Trachoma, Cataract, Partnership, Glaucoma, Center, Intravitreal injection, Severe cognitive impairment, Insert, Time, Joint Medical Service (Germany), Tears, Administration, Antibiotics, Pharmaceutical industry, Risk management

This report features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade.

Key Points: 
  • This report features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade.
  • The growing interest of pharmaceutical stakeholders in this field is also reflected from the recent rise in partnership activity of novel ocular drug delivery device developers.
  • Driven by the increasing patient population and introduction of novel and advanced ocular drug delivery devices, this market is anticipated to witness steady growth in the coming years.
  • Which are the popular types of novel ocular drug delivery devices available in this market?

Anna Luisa Di Lorenzo, MD, FASC is recognized by Continental Who's Who

Retrieved on: 
Friday, November 12, 2021
Family, University, American Academy of Ophthalmology, University School, Music, Royal college, Education, Michigan State Medical Society, Friends, Royal College of Surgeons in Ireland, Continental, Plug-in (computing), Muscle imbalance, Michigan, Wayne, Internal medicine, OCT, Focus: HOPE, Oakland University, American Academy, Human, Glaucoma, Prescription, Wayne State University School of Medicine, Trust Doctor, Detroit Medical Center, Clinical, Cataract, Visual field, Patient, Adult, Pharmaceutical industry, Dentistry

TROY, Mich., Nov. 12, 2021 /PRNewswire/ -- Anna Luisa Di Lorenzo, MD, FASC, is being recognized by Continental Who's Who as a Trusted Doctor in the field of Medicine as a President and Ophthalmologist at Somerset Ophthalmology.

Key Points: 
  • TROY, Mich., Nov. 12, 2021 /PRNewswire/ -- Anna Luisa Di Lorenzo, MD, FASC, is being recognized by Continental Who's Who as a Trusted Doctor in the field of Medicine as a President and Ophthalmologist at Somerset Ophthalmology.
  • As President of Somerset Ophthalmology, Dr. Di Lorenzo is a top Ophthalmologist in Oakland County.
  • Somerset Ophthalmology offers adult and pediatric ophthalmology services to the greater Detroit area at 2877 Crooks Rd, Suite B.
  • Dr. Di Lorenzo dedicates this recognition to Dr. William McCoy, Dr. Jack Baker, and her father Nick Di Lorenzo.

Nordics retailers gain flexible Point of Sale for omnichannel retail with fiscalization of Retail Pro Prism, latest platform from Retail Pro International

Retrieved on: 
Thursday, November 4, 2021
Technology, GRPS, CA, Plug-in (computing), POS, KPI, Language, IOS, UX, API, RPI, Android, COVID, GLOBE, Sale, Music, Warehouse, Retail, Video game

Folsom, CA, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Retail Pro International, developer of the Retail Pro Point of Sale and retail management software named top POS for midmarket retail by IHL Group, has achieved fiscalization in Norway and Sweden for their latest platform, Retail Pro Prism.

Key Points: 
  • Folsom, CA, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Retail Pro International, developer of the Retail Pro Point of Sale and retail management software named top POS for midmarket retail by IHL Group, has achieved fiscalization in Norway and Sweden for their latest platform, Retail Pro Prism.
  • Building on Retail Pro Internationals 20-year presence in the Nordics, fiscalization for the developers latest solution provides specialty retailers in the Nordics with access to advanced technology designed to be the flexible foundation for omnichannel retail .
  • For over 20 years in the Nordics and 35 years worldwide, Retail Pro International has provided a base platform and robust API to allow support of regional requirements specific to a retail management system and point of sale, said Retail Pro International CEO, Kerry Lemos.
  • We at Retail Pro International are committed to helping retailers build their omnichannel strategies on the Retail Pro Prism platform, said Retail Pro International VP EMEAA, Bevin Manian.